Journal of Medicinal Chemistry p. 6759 - 6778 (2018)
Update date:2022-08-15
Topics:
Sharma, Shiv K.
Yip, Christopher
Esposito, Emilio Xavier
Sharma, Prateek V.
Simon, Matthew P.
Abel-Santos, Ernesto
Firestine, Steven M.
Clostridium difficile infections (CDI), particularly those caused by the BI/NAP1/027 epidemic strains, are challenging to treat. One method to address this disease is to prevent the development of CDI by inhibiting the germination of C. difficile spores. Previous studies have identified cholic amide m-sulfonic acid, CamSA, as an inhibitor of spore germination. However, CamSA is inactive against the hypervirulent strain R20291. To circumvent this problem, a series of cholic acid amides were synthesized and tested against R20291. The best compound in the series was the simple phenyl amide analogue which possessed an IC50 value of 1.8 μM, more than 225 times as potent as the natural germination inhibitor, chenodeoxycholate. This is the most potent inhibitor of C. difficile spore germination described to date. QSAR and molecular modeling analysis demonstrated that increases in hydrophobicity and decreases in partial charge or polar surface area were correlated with increases in potency.
View MoreHunan Zhongqi Pharmaceutical Co., Ltd
website:http://www.hnzqzy.com
Contact:0730-8722288 13807308622
Address:Wanjiafan Road ,Yueyang Economic And Technological Development Zone ,Hunan,PRC
Laohekou Jinghong Chemical Co.,Ltd
Contact:+86-0710-3702747
Address:163.East,Huagong Road,Laohekou
Jinan Baozhao Pharmaceutical Co., Ltd
Contact:0086-531-86397156 82371858 82371868
Address:Huaneng Road, Jinan, Shandong ,China
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Doi:10.1002/hlca.19780610728
(1978)Doi:10.1021/jo01313a050
(1980)Doi:10.1002/hlca.19780610828
(1978)Doi:10.1021/ja01260a013
(1942)Doi:10.1055/s-0033-1339693
(2013)Doi:10.1016/S0040-4039(00)97705-0
(1990)